GIVI-MPC

N/A

Report date: 2025/01/26 15:41:25

Base Information

Drug NameGIVI-MPC
Drug Alias Namehuman induced pluripotent stem cell derived myogenic progenitor cells (IPS Heart)GIVI-MPC
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Myogenic potential stem cell therapy
Mechanisms of ActionDystrophin expression stimulants
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIps Heart
China Registration ClassN/A

Develop Information

Active CompaniesIps Heart
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A